Represented Longeveron Inc., a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, in its initial public offering and listing on the Nasdaq Capital Markets.
BodyMedia, a pioneer in developing and marketing wearable body monitors for consumers, in multiple equity financings, as well as its acquisition in August 2013 by Jawbone, a leader and innovator in human-centered wearable technology.
Clear Count Medical Solutions, a medical device start-up, in each of its equity and convertible debt financings since the Company’s inception in 2004.
Tandem Health Care, Inc., a provider of long-term health care services, in its $620 million sale to private equity firms JER Partners and Formation Capital, LLC.
Aethon Inc., a robot and software developer and manufacturer in the health care logistics industry, in its most recent debt and equity financings.
RTI International Metals, Inc. in its securities-related transactions prior to its acquisition, including its public offering of 6.9 million shares of common stock, $230 million Convertible Senior Note offering and $402.5 million Convertible Senior Note offering.
Ongoing representation of Dick's Sporting Goods in securities-related and corporate governance matters and transactions, including its acquisitions of Golf Galaxy (Nasdaq: GGXY) and Chick's Sporting Goods; its tender offer acquisition of Galyan's Trading Company (Nasdaq: GLYN); and its 144A Senior Convertible Notes Offering.
Cellumen, which delivers products and services that support drug discovery and development, in its Series B financing that included investments from Safeguard Scientifics, Inc. and PA Early Stage Partners.
International solar cell and printed electronics company Plextronics, Inc., in multiple equity and debt financing transactions with strategic partners as well as various venture capital firms and banks.
Represents multiple publicly-traded companies with respect to ongoing SEC and SRO compliance matters, including periodic reporting, annual meeting matters and related corporate governance practices.
Represents multiple medical cannabis companies, representing growers, processors and dispensaries, in corporate, financing and M&A matters, along with navigating the regulatory mazes associated with medical marijuana.